Hoag remains safe and ready to care for you. View COVID-19 information and updates.
Hoag Memorial Hospital
Main Menu
  • Specialties & Services
  • Cancer
  • Heart & Vascular
  • Neurosciences
  • Orthopedics
  • Women's Health
  • Other Programs & Services
  • Patients & Visitors
  • Billing Information
  • Gift Shop
  • Infection Prevention
  • Insurance
  • Patient & Visitor Info
  • Patient Stories
  • Online Patient Health Summary
  • Education & Resources
  • Classes
  • Latest News
  • Medical Professional Education
  • Support Groups
  • Videos
  • Locations
  • About Hoag
  • Awards & Accreditations
  • Community Benefit
  • Corporate Information
  • Health Advancements
  • History
  • Hoag Photo Gallery
  • Leadership
  • Mission & Vision
  • News & Publications
  • Patient Stories & Testimonials
  • Quality and Transparency
  • Videos
  • Volunteer
  • Site Map
  • Available Clinical Trials Other Programs & Services
  • Available Clinical Trials
  • Menu
    Cancer Trials
    COVID-19 Trials
    Heart Trials
    Neurosciences Trials
  • Acute Rehabilitation
  • Addiction Medicine
  • Clinical Research
  • Diabetes Center
  • Digestive Health
  • End of Life Care
  • Executive Health
  • Gastrointestinal (GI) Care
  • Hoag Endoscopy Center
  • Hoag HIE
  • Imaging Services
  • Nurse Navigator
  • Melinda Hoag Smith Center for Healthy Living
  • Occupational Therapy
  • Organ and Tissue Donation
  • Outpatient Lab
  • Outpatient Rehabilitation Services
  • Palliative Care
  • Pastoral Care
  • Pelvic Health
  • Pregnancy & Infant Loss
  • Radiology & Imaging Services
  • Respiratory Care
  • Robotics
  • Sleep Disorders
  • Smoking Cessation
  • Speech-Language Pathology
  • Support Groups
  • Thyroid
  • Wound Healing & Hyperbaric Medicine
Specialties & Services Other Programs & Services Clinical Research Available Clinical Trials Cancer Trials Enrolling Cancer Trials Appendix
  • T
    T

Appendix

  • (101-21) A Phase 1 Multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic, Pharmacokinetic Study of Q702 with a Cohort Expansion at the RP2D in Patients with Advanced Solid Tumors

  • (178-18) A Phase 1-2 Study of the Safety, Pharmacokinetics, and Activity of ASTX029 in Subjects With Advanced Solid Tumors

  • (187-19) A Phase 1/2 Study of AGEN1181, an Fc-Engineered Anti-CTLA-4 Monoclonal Antibody as Monotherapy and in Combination With AGEN2034, an Anti-PD-1 Monoclonal Antibody, in Subjects with Advanced Cancer

  • (201-19) A Phase 1 Study of AGEN1223, a Bispecific Fc-Engineered Anti-GITR-OX40 Antibody in Subjects with Advanced Solid Tumors

Certain clinical trials may not be listed on ClinicalTrials.gov. To learn more about these or other clinical trials, please call 949-764-5543 or contact us online.

Enrolling Cancer Trials

  • All Solid Tumors
  • Adrenal
  • Ampullary
  • Anus
  • Appendix
  • Biliary / Gallbladder
  • Bone
  • Brain and Nervous System
  • Breast
  • Cervical
  • Colon / Rectal
  • Esophagus
  • Eye / Orbit
  • Fallopian Tube
  • Head and Neck
  • Kidney / Renal
  • Liver
  • Lung
  • Ovarian
  • Pancreas
  • Penis
  • Peritoneal
  • Prostate
  • Skin
  • Small Intestine
  • Soft Tissue Sarcoma
  • Stomach
  • Testicular
  • Thyroid
  • Urinary Bladder
  • Uterus
  • Vagina
  • Vulva
  • Other Cancers
Sign-Up for Our Newsletter
Next

Quick Links

Appointments Careers Contact Us Insurance Accepted
Online Bill Payment For Medical Professionals Hoag Hospital Foundation Hoag Medical Group
Volunteer Site Map

Follow Us

Hoag Memorial Hospital
Legal Site Map
© 2021 Hoag. All Rights Reserved.